Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation
Circulation · 2026
DOI: 10.1161/circulationaha.125.077494 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Circulation, 2026. Verfasst von Rayan A Ansari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (R.A.A., S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Deep Learning, Electrocardiography, Long QT Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Insitutes of Health, American Heart Association.
Abstract (Originalsprache)
BACKGROUND: Drug-induced QT prolongation after successful inpatient loading of class III antiarrhythmics may occur during routine outpatient care. Insertable cardiac monitors offer continuous signals but are limited by single-lead configuration. We hypothesized that a spatially aware deep learning system (3DRECON-QT) can reconstruct spatial information from a single lead vector to quantify QT/QTc and identify high-risk prolongation. METHODS: We developed 3DRECON-QT using a multitask encoder–decoder that ingests a 10-s single-lead signal, reconstructs 12 leads, and predicts QT/QTc. The model was developed using 12-lead ECGs with clinician-adjudicated QT/RR from a large health system and tested in an external center with different ECG hardware. Continuous monitoring performance was assessed in a public dofetilide‐loading data set with serial ECGs. In a real-world cohort of outpatients on dofetilide or sotalol presenting to the hospital or emergency room for any reason, rates of ventricular arrhythmias and QT prolongation were assessed. Device validation was tested in patients with insertable cardiac monitor recordings paired with clinical 12-lead ECGs. RESULTS: 3DRECON-QT classified prolonged QTc from single-lead signals with area under the receiver operating characteristics curve, 0.942 (mean absolute error, 17.5 ms) in the internal test set and 0.943 (mean absolute error, 21.1 ms) externally. During continuous dofetilide monitoring, predictions correlated with ground truth ( r , 0.851; mean absolute error, 17.8 ms; area under the receiver operating characteristics curve, 0.936 for prolonged QTc, 0.816 for ≥15% QTc rise). QTc prediction from true insertable cardiac monitor recordings showed r =0.824 and mean absolute error, 17.5 ms. In outpatients on class III antiarrhythmics (n=1676), 16.5% had high-risk QTc prolongation. Ventricular arrhythmia events were 3.97% versus 0.86% without prolongation (adjusted odds ratio, 4.24 [95% CI, 1.81–9.90]). 3DRECON-QT detected these events with area under the receiver operating characteristics curve 0.94 (F1 score, 0.60). CONCLUSIONS: A single-lead, deep-learning approach can achieve guideline-level measurement accuracy, enable continuous QTc surveillance from nonstandard ECG vectors, and identify clinically meaningful outpatient QTc prolongation associated with a >4-fold increase in serious ventricular arrhythmias. This strategy may enhance safety monitoring after class III antiarrhythmic initiation and support targeted intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (R.A.A., S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA.
- Department of Biomedical Data Science (R.A.A.), Stanford University, CA.
- Cardiovascular Institute (S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA.
- Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (R.T., D.O.).
- Department of Biomedical Informatics (J.W.H.), Columbia University Irving Medical Center, New York, NY.
- Milstein Division of Cardiology (J.W.H.), Columbia University Irving Medical Center, New York, NY.
ORCID-Profile: Rayan A Ansari, Sabyasachi Bandyopadhyay, Kelly A Brennan, Xichong Liu, Prasanth Ganesan, J Weston Hughes, Alexander C Perino, Euan A Ashley, Paul J Wang, Todd Coleman, Marco V Perez, David Ouyang, Sanjiv M Narayan, Albert J Rogers
Förderung
- NHLBI NIH HHS
- National Insitutes of Health
- American Heart Association
- National Institutes of Health
Zitieren
APA
Ansari, R. A., Bandyopadhyay, S., Trivedi, R. K., Brennan, K. A., Liu, X., Ganesan, P., Hughes, J. W., Perino, A. C., Ashley, E. A., Wang, P. J., Coleman, T., Perez, M. V., Ouyang, D., Narayan, S. M., & Rogers, A. J. (2026). Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Circulation. https://doi.org/10.1161/circulationaha.125.077494
Vancouver
Ansari RA, Bandyopadhyay S, Trivedi RK, Brennan KA, Liu X, Ganesan P, et al. Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Circulation. 2026. doi:10.1161/circulationaha.125.077494
BibTeX
@article{Ansari2026,
author = {Ansari, Rayan A and Bandyopadhyay, Sabyasachi and Trivedi, Rishi K and Brennan, Kelly A and Liu, Xichong and Ganesan, Prasanth and Hughes, J Weston and Perino, Alexander C and Ashley, Euan A and Wang, Paul J and Coleman, Todd and Perez, Marco V and Ouyang, David and Narayan, Sanjiv M and Rogers, Albert J},
title = {Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.125.077494}
}
EUVIMED